Diabetic eye screening: escalation process for non-submission of evidence
Updated 27 September 2024
Applies to England
© Crown copyright 2024
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit nationalarchives.gov.uk/doc/open-government-licence/version/3 or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at https://www.gov.uk/government/publications/diabetic-eye-screening-internal-and-external-quality-assurance/diabetic-eye-screening-escalation-process-for-non-submission-of-evidence
The screening service should provide evidence to the screening quality assurance service (SQAS) at least 10 weeks before the QA visit date.
SQAS should follow the escalation process below if evidence has not been provided by 9 weeks before the visit. The process is described below in text format and as an illustration.
Send reminder to programme manager
SQAS sends reminder to programme manager 9 weeks before QA visit date.
Is evidence received by 8 weeks before visit?
Yes: Evidence used at QA visit. End of pathway
No: Send second reminder to programme manager at 8 weeks minus one day before visit date, informing them of the absolute deadline of 7 weeks before visit. Contact clinical lead by phone and follow up by email, quoting the absolute deadline. Go to question 3.
Is evidence received by 7 weeks minus 2 days before visit?
Yes: Evidence used at QA visit. End of pathway.
No: If proforma or outstanding evidence is not received by the absolute deadline, SQAS should inform the medical director and the clinical lead within 48 hours of the missed deadline. Also inform the commissioner and the screening and immunisation team (SIT).
Make an immediate recommendation at the QA visit that the programme should provide the outstanding information, or confirmation it does not exist within 7 days, along with an agreed date for discussion with SQAS. End of pathway.
